Selinexor, a First-in-Class XP01 Inhibitor, is Efficacious and Tolerable in Patients with Myelodysplastic Syndromes (MDS) Refractory to Hypomethylating Agents
Selinexor, a First-in-Class XP01 Inhibitor, is Efficacious and Tolerable in Patients with Myelodysplastic Syndromes (MDS) Refractory to Hypomethylating Agents